SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Leung LTF, Papp A. Burns 2018; 44(3): 646-650.

Affiliation

Division of Plastic & Reconstructive Surgery, University of British Columbia, Vancouver, B.C., Canada.

Copyright

(Copyright © 2018, Elsevier Publishing)

DOI

10.1016/j.burns.2017.10.010

PMID

29100677

Abstract

BACKGROUND: Accelerants are flammable substances that may cause explosion when added to existing fires. The relationships between drug abuse and accelerant-related burns are not well elucidated in the literature. Of these burns, a portion is related to drug manufacturing, which have been shown to be associated with increased burn complications.

OBJECTIVES: 1) To evaluate the demographics and clinical outcomes of accelerant-related burns in a Provincial Burn Centre. 2) To compare the clinical outcomes with a control group of non-accelerant related burns. 3) To analyze a subgroup of patients with history of drug abuse and drug manufacturing.

METHODS: Retrospective case control study. Patient data associated with accelerant-related burns from 2009 to 2014 were obtained from the British Columbia Burn Registry. These patients were compared with a control group of non-accelerant related burns. Clinical outcomes that were evaluated include inhalational injury, ICU length of stay, ventilator support, surgeries needed, and burn complications. Chi-square test was used to evaluate categorical data and Student's t-test was used to evaluate mean quantitative data with the p value set at 0.05. A logistic regression model was used to evaluate factors affecting burn complications.

RESULTS: Accelerant-related burns represented 28.2% of all burn admissions (N=532) from 2009 to 2014. The accelerant group had higher percentage of patients with history of drug abuse and was associated with higher TBSA burns, ventilator support, ICU stay and pneumonia rates compared to the non-accelerant group. Within the accelerant group, there was no difference in clinical outcomes amongst people with or without history of drug abuse. Four cases were associated with methamphetamine manufacturing, all of which underwent ICU stay and ventilator support.

CONCLUSIONS: Accelerant-related burns cause significant burden to the burn center. A significant proportion of these patients have history of drug abuse.

Copyright © 2017 Elsevier Ltd and ISBI. All rights reserved.


Language: en

Keywords

Accelerant; Burn; Butane; Complications; Drug abuse; Methamphetamines; Outcomes; Propane

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print